Evommune EVMN
NYSE EVMN
$7.06 -0.15 (-2.04%)
As of: Oct 2, 2026 · 11:05 AM EDT

Evommune (EVMN) Short-term Investments (2024 - 2026)

Updated

Evommune's Short-term Investments came in at $140.76 million for Q2 2026, down 13.7% from the prior quarter.

Analysis

Evommune (EVMN) Short-term Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, Evommune's Short-term Investments was $105.14 million, up 88.5% from FY2024.

  • Going back by year, Short-term Investments was $55.79 million in FY2024.
  • The five-year range for quarterly Short-term Investments is $49.24 million (Q3 2025) to $163.15 million (Q1 2026).
  • Business Quant data shows EVMN's Short-term Investments at $163.15 million (Q1 2026), $105.14 million (Q4 2025) and $49.24 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Evommune 299.69 Mn -337.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140.76 Mn
Mar 31, 2026 163.15 Mn
Dec 31, 2025 105.14 Mn
Sep 30, 2025 49.24 Mn
Dec 31, 2024 55.79 Mn
API Access

Evommune Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=EVMN&period=max&api_key=YOUR_API_KEY